The Diverse Presentation of Pediatric Hemophagocytic Lymphohistiocytosis in a Philippine Tertiary Hospital: A Case Series

Clicks: 13
ID: 327316
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #111 of 147 articles by views in journal of the pediatric infectious diseases society

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 147 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome with high mortality in children. In resource-limited settings with high infectious burdens, the diagnosis is particularly challenging as HLH masquerades as severe, common infections. This case series describes the presentation, triggers, and outcomes of pediatric HLH in the Philippines, highlighting the unique diagnostic and management hurdles. Methods A retrospective, descriptive case series was conducted at a Philippine tertiary hospital. We reviewed the medical records of four pediatric patients (aged 2-18 years) diagnosed with HLH based on established clinical and laboratory criteria. Results Four cases were identified with a striking diversity of infectious triggers: SARS-CoV-2, Typhoid Fever, Disseminated Histoplasmosis, and Toxoplasmosis. All patients presented with the classic triad of prolonged fever (8 days to 6 months), hepatosplenomegaly, and significant cytopenias. Laboratory confirmation was marked by profound hyperferritinemia (peak 18,180 ng/mL), hypertriglyceridemia (peak 1,039 mg/dL), and elevated LDH, corresponding to high H-Scores (151-319). A critical observation was the tempo of presentation: viral and bacterial triggers caused hyperacute illness (<2 weeks), while the fungal trigger (Histoplasmosis) presented as a chronic, 6-month indolent fever, significantly delaying diagnosis. Management involved trigger-directed antimicrobials and varied immunomodulation. Two patients received aggressive HLH therapy (IVIG, steroids, etoposide, cyclosporine), one received IVIG alone, and one received only antifungals. Outcomes were heterogeneous: two patients improved, one was discharged against medical advice following antifungal therapy, and one died despite maximal therapy. The mortality underscores the syndrome's ferocity, while the discharge against medical advice reflects profound socio-economic challenges in this setting. Conclusion This series underscores that HLH must be a primary diagnostic consideration in any child with persistent fever and cytopenias in high-infection burden regions. The varied infectious triggers and clinical courses demand a high index of suspicion. Optimal management requires a dual, simultaneous strategy: aggressive treatment of the underlying infection and timely, protocol-driven immunomodulation to control the cytokine storm. These findings highlight the need for improved diagnostic awareness and adapted treatment protocols in resource-limited environments.
Reference Key
openalex_W7204644655 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mary Crist Jamora, Sabrina Villanueva, Annie Grail Lidua, Natalie Keith Solonio
Are you one of these authors? Claim your profile
Journal journal of the pediatric infectious diseases society
Year 2026
DOI
10.1093/jpids/piag070/piag070.051
URL
https://academic.oup.com/jpids/article-pdf/15/Supplement_2/S22/70833276/piag070.051.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.